These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1851385)

  • 21. First-line treatment of advanced nonsmall cell lung carcinoma with docetaxel and vinorelbine.
    Kourousis C; Androulakis N; Kakolyris S; Souglakos J; Maltezakis G; Metaxaris G; Chalkiadakis G; Samonis G; Vlachonikolis J; Georgoulias V
    Cancer; 1998 Nov; 83(10):2083-90. PubMed ID: 9827712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase II trial of weekly intravenous vinorelbine in first-line advanced breast cancer chemotherapy.
    Fumoleau P; Delgado FM; Delozier T; Monnier A; Gil Delgado MA; Kerbrat P; Garcia-Giralt E; Keiling R; Namer M; Closon MT
    J Clin Oncol; 1993 Jul; 11(7):1245-52. PubMed ID: 8315421
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer.
    Kusumoto S; Hirose T; Fukayama M; Kataoka D; Hamada K; Sugiyama T; Shirai T; Yamaoka T; Okuda K; Ohnishi T; Ohmori T; Kadokura M; Adachi M
    Oncol Rep; 2009 Nov; 22(5):1157-62. PubMed ID: 19787234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase I study of vinorelbine and carboplatin in advanced non-small cell lung cancer.
    Jacoulet P; Breton JL; Westeel V; Mercier M; Garnier G; Depierre A
    Lung Cancer; 1995 Jun; 12(3):247-57. PubMed ID: 7655834
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vinorelbine. A review of its antitumour activity in lung cancer.
    Sørensen JB
    Drugs; 1992; 44 Suppl 4():60-5; discussion 66-9. PubMed ID: 1283851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
    Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral vinorelbine and cisplatin as induction chemotherapy and concomitant chemo-radiotherapy in stage III non-small cell lung cancer: final results of an international phase II trial.
    Krzakowski M; Provencio M; Utracka-Hutka B; Villa E; Codes M; Kuten A; Henke M; Lopez M; Bell D; Biti G; Merimsky O; Beorchia A; Riggi M; Caux NR; Pouget JC; Dubray B; David P
    J Thorac Oncol; 2008 Sep; 3(9):994-1002. PubMed ID: 18758302
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Continuous-infusion vinorelbine for the treatment of advanced non-small-cell lung cancer: a phase I/II study.
    Carabante-Ocón F; Cobo-Dols M; Benavides-Orgaz M; Gil-Calle S; Alés-Díaz I; Bretón-García JJ; Villar-Chamorro E; Montesa-Pino A; Alcalde-García J; Gutiérrez-Calderón V
    Clin Lung Cancer; 2005 Sep; 7(2):121-6. PubMed ID: 16179099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vinorelbine (navelbine) as a salvage treatment for advanced breast cancer.
    Degardin M; Bonneterre J; Hecquet B; Pion JM; Adenis A; Horner D; Demaille A
    Ann Oncol; 1994 May; 5(5):423-6. PubMed ID: 8075049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vinorelbine (Navelbine) in non-small cell lung cancer: future directions.
    Crawford J
    Semin Oncol; 1994 Oct; 21(5 Suppl 10):85-8. PubMed ID: 7526468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase II study with vinorelbine and cisplatin in advanced non-small cell lung cancer after failure of previous chemotherapy.
    Chen YM; Lee CS; Lin WC; Tsai CM; Perng RP
    J Chin Med Assoc; 2003 Apr; 66(4):241-6. PubMed ID: 12854877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of weekly i.v. vinorelbine as a single agent in first-line advanced breast cancer chemotherapy. The Latin-American experience.
    Bruno S; Puerto VL; Mickiewicz E; Hegg R; Texeira LC; Gaitan L; Martinez L; Fernandez O; Otero J; Kesselring G
    Am J Clin Oncol; 1995 Oct; 18(5):392-6. PubMed ID: 7572754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. EORTC Lung Cancer Cooperative Group.
    Jassem J; Karnicka-Młodkowska H; van Pottelsberghe C; van Glabbeke M; Noseda MA; Ardizzoni A; Gozzelino F; Planting A; van Zandwijk N
    Eur J Cancer; 1993; 29A(12):1720-2. PubMed ID: 8398301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Weekly vinorelbine in elderly patients with non-small-cell lung cancer.
    Colleoni M; Gaion F; Nelli P; Colmellere GM; Manente P
    Tumori; 1994 Dec; 80(6):448-52. PubMed ID: 7900235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group B.
    Richards F; Perry DJ; Goutsou M; Modeas C; Muchmore E; Rege V; Chahinian AP; Hirsh V; Poiesz B; Green MR
    Cancer; 1991 Jun; 67(12):2974-9. PubMed ID: 1646066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II study of vinorelbine, mitomycin C and cisplatin chemotherapy for advanced non-small cell lung cancer.
    Kwon MR; Jeong TY; Yuh YJ; Kim SR
    Korean J Intern Med; 2002 Dec; 17(4):240-4. PubMed ID: 12647638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cost-effectiveness of navelbine alone or in combination with cisplatin in comparison to other chemotherapy regimens and best supportive care in stage IV non-small cell lung cancer.
    Evans WK; Le Chevalier T
    Eur J Cancer; 1996 Dec; 32A(13):2249-55. PubMed ID: 9038606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness analysis of three regimens using vinorelbine (Navelbine) for non-small cell lung cancer.
    Hillner BE; Smith TJ
    Semin Oncol; 1996 Apr; 23(2 Suppl 5):25-30. PubMed ID: 8610234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vinorelbine monochemotherapy in non-small-cell lung cancer: experience in patients with low performance status.
    Masotti A; Zannini G; Poggi R; Morandini GC
    Monaldi Arch Chest Dis; 1994 Jun; 49(3):197-200. PubMed ID: 8087113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II study of oral vinorelbine in combination with carboplatin followed by consolidation therapy with oral vinorelbine as single-agent in unresectable localized or metastatic non-small cell lung carcinoma.
    Reck M; Macha HN; Del Barco S; Cornes P; Vaissière N; Morand M; Riggi M; Abratt R
    Lung Cancer; 2009 Jun; 64(3):319-25. PubMed ID: 19095327
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.